BAKER BROS. ADVISORS LP
BAKER BROS. ADVISORS LP reported 80 positions worth $21.04B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: INCY (17.7%). Biggest move: reduce CELC ($246.5M).
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | INCY | $3.73B | 17.74% | 30,762,652 | — | — | -0.9% | |
| ▸ 2 | ONC | $3.23B | 15.36% | 8,832,335 | — | — | +12.4% | |
| ▸ 3 | RVMD | $2.18B | 10.38% | 10,637,318 | — | — | -18.7% | |
| ▸ 4 | KOD | $2.07B | 9.85% | 21,860,941 | — | — | +6.3% | |
| ▸ 5 | MDGL | $1.08B | 5.13% | 2,143,131 | — | — | -15.9% | |
| ▸ 6 | INSM | $1.00B | 4.77% | 8,796,111 | — | — | +7.7% | |
| ▸ 7 | KYMR | $967.8M | 4.60% | 8,657,242 | — | — | +14.1% | |
| ▸ 8 | ACAD | $864.7M | 4.11% | 42,912,904 | — | — | -6.9% | |
| ▸ 9 | GRAL | $564.5M | 2.68% | 4,028,614 | — | — | -17.3% | |
| ▸ 10 | SMMT | $554.4M | 2.63% | 32,786,348 | — | — | -16.3% |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does BAKER BROS. ADVISORS LP hold as of Q3 2026?
BAKER BROS. ADVISORS LP reported 80 positions worth $21.04B in its Q3 2026 13F filing. Largest positions: INCY (17.7%), ONC (15.4%), RVMD (10.4%), KOD (9.8%) and MDGL (5.1%).
What did BAKER BROS. ADVISORS LP buy in Q3 2026?
New positions: TRAX, SCTX, FRNM, QTTB and Skye Bioscience, Inc.. Added to: KOD, CLDX, ONC, MPLT and DSGN (9 in all).
What did BAKER BROS. ADVISORS LP sell in Q3 2026?
Reduced: CELC, RVMD, IMVT, STOK and IMTX (11 in all). Sold out entirely: CRNXGBP, ALMS, VRDN, SION and VSTM (9 in all).
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.